Management of osteoporosis
Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 10
Abstract
Osteoporosis is a major neglected public health problem associated with significant morbidity and mortality. Treatment in a patient with osteoporosis is targeted at reducing the future fracture risk, which is achieved through a combination of non-pharmacological and pharmacological interventions. Education on simple measures aimed at fall prevention, and adequate calcium and vitamin D supplementation should be ensured in all patients treated for osteoporosis. Medications approved for treatment of osteoporosis include antiresorptive agents (estrogen, calcitonin, selective estrogen receptor modulator raloxifene, bisphosphonates and denosumab) and anabolic agents (teriparatide and abaloparatide). A search for newer treatment targets has enabled development of two new effective drugs-odanacatib and romosozumab. However, these drugs have not been approved due to increased risk of stroke and cardiovascular events seen in the study participants. At present, combination therapy with anabolic and antiresorptive agents is not recommended due to lack of data on antifracture efficacy and cost-effectiveness. The sequential therapy should comprise of anabolic agent first, followed by an antiresorptive agent to maintain the bone mineral density (BMD) gains achieved with the initial treatment. BMD should be monitored periodically and increasing (or maintained) areal BMD without incident fractures indicates successful treatment.
Authors and Affiliations
Alpesh Goyal, Nikhil Tandon
Keywords
Related Articles
- EP ID EP615977
- DOI -
- Views 133
- Downloads 0
Heart Failure with Preserved Ejection Fraction (HFpEF)
It has been estimated that Heart Failure with Preserved Ejection Fraction (HFpEF) may account for over 60% of patients hospitalized for HF. Key haemodynamic alterations in HFpEF include subtle systolic dysfunction (depic...
Basal insulin supported oral therapy in type 2 diabetes
Early intensive glycemic control in type 2 diabetes reduces the risk of long-term complications, and often requires timely initiation and optimization of insulin therapy. While there are several patient and physician-rel...
Intracerebral changes detected by CT scan of brain in eclampsia
To evaluate the different neurological changes in brain in eclampsia by CT scan in relation to neurologic symptoms. This is prospective observational study in a tertiary hospital. CT scan of brain is performed within 48...
An analysis of 30 cases of myelodysplastic syndrome
30 Cases of MDS presented from April 98 to May 2006 are included in this study. 15 cases were male and 15 cases were female. Mean age at presentation was 55 years (range 8-73 years). Majority of patients presented with w...
Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device : one-year outcomes of Fiona-1 clinical registry
The objective of the Fiona-1 registry (CTRI/2016/03/006781) is to assess the safety and performance of levonorgestrel-releasing intrauterine device (LNG-IUD), Fiona. This was a prospective, open-label, single-arm study c...